United States Organ-on-a-Chip Market By Device (Liver-on-a-Chip, Lung-on-a-Chip, Intestine-on-a-Chip, Kidney-on-a-Chip, Heart-on-a-Chip, Others), By Application (Drug Discovery, Toxicology Research, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F
Market Report I 2025-09-30 I 85 Pages I TechSci Research
Market Overview
United States Organ-on-a-Chip Market was valued at USD 68.20 Million in 2024 and is expected to reach USD 91.14 Million by 2030 with a CAGR of 5.15%. This emerging technology simulates human organ functions on micro-engineered platforms, offering a high level of physiological relevance that cannot be matched by conventional animal models. As a result, pharmaceutical and biotechnology companies are showing heightened interest in integrating these systems into their research and development pipelines to improve the predictability of preclinical results and reduce costly late-stage failures.
Despite its promise, the market is not without challenges. Technical complexity remains a significant barrier, as operating and maintaining these systems requires specialized expertise and infrastructure. In addition, cost considerations and scalability limitations continue to affect their broader implementation, particularly in resource-constrained settings. However, continued investment in automation, standardization, and user-friendly design is expected to gradually mitigate these issues and expand access across the industry.
Key Market Drivers
Growth in Healthcare Industry
The rapid expansion of the healthcare industry in the United States is a key driver fueling the growth of the organ-on-a-chip (OoC) market. Healthcare represents a significant component of national economies, accounting for over 10% of the gross domestic product (GDP) in most developed countries. In the United States, healthcare expenditures increased by 2.7% in 2021, totaling USD 4.3 trillion or approximately USD 12,914 per capita. As healthcare providers, pharmaceutical companies, and research institutions increasingly prioritize personalized medicine, drug development, and predictive toxicology, the demand for advanced in-vitro models such as organ-on-a-chip is surging.
In 2022, the United States Congress enacted the FDA Modernization Act 2.0, permitting the use of alternative preclinical testing methods as a substitute for traditional animal testing. The rising focus on improving the efficiency and accuracy of preclinical testing has led to a shift away from traditional animal models, which often fail to replicate human physiological responses. Organ-on-a-chip technologies offer a more reliable and cost-effective alternative by simulating human organ functions on microfluidic devices. This innovation aligns with the broader healthcare industry's goal of accelerating drug discovery while reducing R&D costs and ethical concerns.
Key Market Challenges
High Costs & Complex Manufacturing
One of the primary challenges facing the United States Organ-on-a-Chip market is the high cost and complexity associated with manufacturing these advanced microfluidic devices. The intricate design and fabrication processes require precision engineering, specialized materials, and sophisticated microfabrication techniques, which collectively contribute to elevated production expenses. These costs extend beyond initial manufacturing to include ongoing maintenance, quality control, and validation efforts, making the overall investment substantial.
Moreover, the complexity inherent in producing reliable and reproducible organ-on-a-chip platforms poses significant barriers to scalability and mass production. Each device must meet stringent biological and engineering specifications to accurately mimic human organ functions, demanding multidisciplinary expertise and extensive R&D efforts. This technical sophistication limits the ability of smaller companies and research institutions to independently manufacture these chips, often necessitating partnerships with specialized contract manufacturers or service providers.
Key Market Trends
Rise of Personalized Medicine
The rise of personalized medicine is emerging as a pivotal trend shaping the United States organ-on-a-chip (OoC) market. Personalized medicine, which focuses on tailoring medical treatment to the individual characteristics of each patient, demands highly precise and predictive models to understand patient-specific drug responses and disease mechanisms. Organ-on-a-chip technology addresses this need by replicating the microenvironment of human organs with high fidelity, enabling more accurate simulation of how a particular patient's cells might react to different therapies.
This trend is driven by advancements in genomics, biotechnology, and data analytics, which collectively support the shift towards treatments that are customized rather than one-size-fits-all. The integration of cells from multiple organs within a single chip enables a more holistic approach to drug screening, toxicology assessment, biomarker identification, cancer research, and disease modeling, including Parkinson's disease. The broad range of available cell lines provides substantial flexibility in selecting the most suitable research materials. Organ-on-a-chip devices facilitate this by providing platforms where patient-derived cells can be cultured to test drug efficacy and toxicity on a personalized level, thereby minimizing adverse effects and improving therapeutic outcomes.
Key Market Players
- Emulate, Inc.
- MIMETAS B.V.
- Valo Health
- Quris Technologies LTD.
- AxoSim
- BICO - THE BIO CONVERGENCE COMPANY
- CN Bio Innovations Ltd
- The Charles Stark Draper Laboratory, Inc.
- SynVivo, Inc.
- AlveoliX AG
Report Scope
In this report, the United States Organ-on-a-Chip Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- United States Organ-on-a-Chip Market, By Device:
o Liver-on-a-Chip
o Lung-on-a-Chip
o Intestine-on-a-Chip
o Kidney-on-a-Chip
o Heart-on-a-Chip
o Others
- United States Organ-on-a-Chip Market, By Application:
o Drug Discovery
o Toxicology Research
o Others
- United States Organ-on-a-Chip Market, By Region:
o Northeast
o Midwest
o South
o West
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the United States Organ-on-a-Chip Market.
Available Customizations:
United States Organ-on-a-Chip Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Impact of COVID-19 on United States Organ-on-a-Chip Market
5. United States Organ-on-a-Chip Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Device (Liver-on-a-Chip, Lung-on-a-Chip, Intestine-on-a-Chip, Kidney-on-a-Chip, Heart-on-a-Chip, Others)
5.2.2. By Application (Drug Discovery, Toxicology Research, Others)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
6. Northeast Organ-on-a-Chip Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Device
6.2.2. By Application
7. Midwest Organ-on-a-Chip Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Device
7.2.2. By Application
8. South Organ-on-a-Chip Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Device
8.2.2. By Application
9. West Organ-on-a-Chip Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Device
9.2.2. By Application
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
11.1. Merger & Acquisition (If Any)
11.2. Product Launches (If Any)
11.3. Recent Developments
12. Disruptions: Conflicts, Pandemics and Trade Barriers
13. United States Organ-on-a-Chip Market: SWOT Analysis
14. Porters Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Emulate, Inc.
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. MIMETAS B.V.
15.3. Valo Health
15.4. Quris Technologies LTD.
15.5. AxoSim
15.6. BICO - THE BIO CONVERGENCE COMPANY
15.7. CN Bio Innovations Ltd
15.8. The Charles Stark Draper Laboratory, Inc.
15.9. SynVivo, Inc.
15.10. AlveoliX AG
16. Strategic Recommendations
17. About Us & Disclaimer
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.